HB 1702 New Hampshire House · 2026 Regular Session

relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

HB 1702 requires pharmacies and medical facilities in New Hampshire to post a standardized notice about mifepristone (a drug used for chemical abortions) when dispensing it. The notice, displayed prominently in specific areas like waiting rooms or pharmacy counters, states that mifepristone may sometimes be reversible if the second pill hasn’t been taken, and provides a contact for resources. Noncompliance could result in a class B felony charge for providers or civil lawsuits seeking damages for patients harmed by the lack of notice. The bill directly affects pharmacies and clinics dispensing mifepristone, with no estimated state or local costs.
Bill status died 1 of 4 stages cleared
Introduction
Dec 2025
Committee Review
Floor Vote
Governor
Introduced Dec 12, 2025 Last action Feb 27, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
1
Feb 27, 2026
Committee
Committee Report: Inexpedient to Legislate 02/13/2026 (Vote 17-0; RC) HC 10 P. 102
lower
Dec 12, 2025
Introduced
Introduced 01/07/2026 and referred to Judiciary HJ 1 P. 32
lower
0 primary · 9 co-sponsors

Sponsors

No sponsor information available.